Glyceryl Mono- And Dicaprylocaprate

ExcipientCAS 85536-07-8UNII U72Q2I8C85

2 organisations hold 2 active FDA Type IV Drug Master Files for Glyceryl Mono- And Dicaprylocaprate. 1 further filing is inactive and shown as history.

Sources: FDA List of Drug Master Files (checked 13 Nov 2026); FDA Global Substance Registration System (identity). Methodology

Active Type IV DMFs (2)

HolderDMFFiled asSubmitted
HUBEI GEDIAN HUMANWELL PHARMACEUTICAL EXCIPIENTS CO LTD
China
36199GLYCERYL MONO AND DICAPRYLOCAPRATENov 2021
IOI OLEO GMBH
Germany
35668IMWITOR® 742 (GLYCERYL MONO AND DICAPRYLOCAPRATE)Mar 2021

“Filed as” is the subject exactly as the holder gave it to the FDA, including the grade or pharmacopoeia it names. Holder names link to a company profile where one is published. An active filing can be referenced by a drug application; it is not proof of current supply.

Inactive filings (1)

  • CREMER OLEO GMBH AND CO KG · IMWITOR 742DMF 10508 · Sept 1993

Inactive filings are closed or lapsed and cannot be referenced. They are shown as history only.

What these records establish

  • A Type IV DMF is a confidential file held by the FDA for an excipient, colourant or flavour. The FDA does not approve or disapprove it; it is reviewed when a drug application references it.
  • Active means the file is open and can be referenced with the holder's letter of authorisation. It says nothing about price, capacity or current availability.
  • The holder is the organisation that filed. It is usually, but not always, the manufacturer.
  • Many excipients are supplied without any DMF, so this list is not every supplier of Glyceryl Mono- And Dicaprylocaprate.

How to qualify an excipient supplier

For suppliers

Do you supply Glyceryl Mono- And Dicaprylocaprate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.